117 related articles for article (PubMed ID: 36812708)
21. Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy.
Hingtgen SD; Tian X; Yang J; Dunlay SM; Peek AS; Wu Y; Sharma RV; Engelhardt JF; Davisson RL
Physiol Genomics; 2006 Aug; 26(3):180-91. PubMed ID: 16670255
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-384-mediated Herpud1 upregulation promotes angiotensin II-induced endothelial cell apoptosis.
Lin H; Pan S; Meng L; Zhou C; Jiang C; Ji Z; Chi J; Guo H
Biochem Biophys Res Commun; 2017 Jul; 488(3):453-460. PubMed ID: 28483519
[TBL] [Abstract][Full Text] [Related]
23. [MicroRNA-23a knockdown attenuates angiotensin Ⅱ induced hypertrophy in rat H9c2 cells via activating PTEN and AMPK pathway].
Teng W; Zheng XJ; Gong GH; He ZH
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):329-335. PubMed ID: 32370485
[No Abstract] [Full Text] [Related]
24. Sialyltransferase7A promotes angiotensin II-induced cardiomyocyte hypertrophy via HIF-1α-TAK1 signalling pathway.
Yan X; Zhao R; Feng X; Mu J; Li Y; Chen Y; Li C; Yao Q; Cai L; Jin L; Han C; Zhang D
Cardiovasc Res; 2020 Jan; 116(1):114-126. PubMed ID: 30854566
[TBL] [Abstract][Full Text] [Related]
25. Aberrant interaction of calmodulin with the ryanodine receptor develops hypertrophy in the neonatal cardiomyocyte.
Gangopadhyay JP; Ikemoto N
Biochem J; 2011 Sep; 438(2):379-87. PubMed ID: 21649588
[TBL] [Abstract][Full Text] [Related]
26. TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy.
Onohara N; Nishida M; Inoue R; Kobayashi H; Sumimoto H; Sato Y; Mori Y; Nagao T; Kurose H
EMBO J; 2006 Nov; 25(22):5305-16. PubMed ID: 17082763
[TBL] [Abstract][Full Text] [Related]
27. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
[TBL] [Abstract][Full Text] [Related]
28. Sodium butyrate attenuates angiotensin II-induced cardiac hypertrophy by inhibiting COX2/PGE2 pathway via a HDAC5/HDAC6-dependent mechanism.
Zhang L; Deng M; Lu A; Chen Y; Chen Y; Wu C; Tan Z; Boini KM; Yang T; Zhu Q; Wang L
J Cell Mol Med; 2019 Dec; 23(12):8139-8150. PubMed ID: 31565858
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2.
Yu XJ; Huang YQ; Shan ZX; Zhu JN; Hu ZQ; Huang L; Feng YQ; Geng QS
Life Sci; 2019 Sep; 232():116635. PubMed ID: 31283925
[TBL] [Abstract][Full Text] [Related]
30. Let-7a Is an Antihypertrophic Regulator in the Heart via Targeting Calmodulin.
Zhou X; Sun F; Luo S; Zhao W; Yang T; Zhang G; Gao M; Lu R; Shu Y; Mu W; Zhuang Y; Ding F; Xu C; Lu Y
Int J Biol Sci; 2017; 13(1):22-31. PubMed ID: 28123343
[No Abstract] [Full Text] [Related]
31. MiR-181a mediates Ang II-induced myocardial hypertrophy by mediating autophagy.
Li AL; Lv JB; Gao L
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5462-5470. PubMed ID: 29243791
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin II-induced histone deacetylase 5 phosphorylation, nuclear export, and Egr-1 expression are mediated by Akt pathway in A10 vascular smooth muscle cells.
Truong V; Jain A; Anand-Srivastava MB; Srivastava AK
Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1543-H1554. PubMed ID: 33606583
[TBL] [Abstract][Full Text] [Related]
33. DPP (Dipeptidyl Peptidase)-4 Inhibitor Attenuates Ang II (Angiotensin II)-Induced Cardiac Hypertrophy via GLP (Glucagon-Like Peptide)-1-Dependent Suppression of Nox (Nicotinamide Adenine Dinucleotide Phosphate Oxidase) 4-HDAC (Histone Deacetylase) 4 Pathway.
Okabe K; Matsushima S; Ikeda S; Ikeda M; Ishikita A; Tadokoro T; Enzan N; Yamamoto T; Sada M; Deguchi H; Shinohara K; Ide T; Tsutsui H
Hypertension; 2020 Apr; 75(4):991-1001. PubMed ID: 32160098
[TBL] [Abstract][Full Text] [Related]
34. Ca²⁺ signal-induced cardiomyocyte hypertrophy through activation of myocardin.
Li M; Wang N; Gong HQ; Li WZ; Liao XH; Yang XL; He HP; Cao DS; Zhang TC
Gene; 2015 Feb; 557(1):43-51. PubMed ID: 25485719
[TBL] [Abstract][Full Text] [Related]
35. EndophilinA2 protects against angiotensin II-induced cardiac hypertrophy by inhibiting angiotensin II type 1 receptor trafficking in neonatal rat cardiomyocytes.
Liu Y; Shen HJ; Wang XQ; Liu HQ; Zheng LY; Luo JD
J Cell Biochem; 2018 Nov; 119(10):8290-8303. PubMed ID: 29923351
[TBL] [Abstract][Full Text] [Related]
36. Pressure overload-induced cardiac hypertrophy response requires janus kinase 2-histone deacetylase 2 signaling.
Ying H; Xu MC; Tan JH; Shen JH; Wang H; Zhang DF
Int J Mol Sci; 2014 Nov; 15(11):20240-53. PubMed ID: 25380525
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin II-induced cardiomyocyte hypertrophy in vitro is TAK1-dependent and Smad2/3-independent.
Watkins SJ; Borthwick GM; Oakenfull R; Robson A; Arthur HM
Hypertens Res; 2012 Apr; 35(4):393-8. PubMed ID: 22072105
[TBL] [Abstract][Full Text] [Related]
38. Cooperative interaction between reactive oxygen species and Ca2+ signals contributes to angiotensin II-induced hypertrophy in adult rat cardiomyocytes.
Gul R; Shawl AI; Kim SH; Kim UH
Am J Physiol Heart Circ Physiol; 2012 Feb; 302(4):H901-9. PubMed ID: 22140048
[TBL] [Abstract][Full Text] [Related]
39. 3,3'-Diindolylmethane attenuates cardiac H9c2 cell hypertrophy through 5'-adenosine monophosphate-activated protein kinase-α.
Zong J; Wu QQ; Zhou H; Zhang JY; Yuan Y; Bian ZY; Deng W; Dai J; Li FF; Xu M; Fang Y; Tang QZ
Mol Med Rep; 2015 Jul; 12(1):1247-52. PubMed ID: 25816057
[TBL] [Abstract][Full Text] [Related]
40. Involvement of vascular peroxidase 1 in angiotensin II-induced hypertrophy of H9c2 cells.
Yang W; Liu Z; Xu Q; Peng H; Chen L; Huang X; Yang T; Yu Z; Cheng G; Zhang G; Shi R
J Am Soc Hypertens; 2017 Aug; 11(8):519-529.e1. PubMed ID: 27651140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
